Claritas Pharmaceuticals, Inc.
Claritas Pharmaceuticals, Inc. (CLAZF) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
CLAZF · net income · updated Jun 9, 2026
Core profitability metrics
CLAZF · net income · margin · TTM · CAGRNet income was $4.2M for FY2020 (fiscal year ending 2020-12-31), up 119.8% year-over-year. Net profit margin was —. Based on available data, Claritas Pharmaceuticals, Inc. has been profitable since at least 2018.
Annual net income history
▸ FMP /income-statement · Annual · CLAZF net income history · CLAZF profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Claritas Pharmaceuticals, Inc. (CLAZF) reported net income of $4.2M for FY2020 (fiscal year ending 2020-12-31), up 119.8% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Based on available data, Claritas Pharmaceuticals, Inc. has been profitable since at least 2018. Net income reached a peak of $6.9M in FY2018. Data available for 15 fiscal years.
Claritas Pharmaceuticals, Inc.'s net profit margin was — for FY2020, based on the latest annual results.
Investors sometimes search for "Claritas Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from CLAZF net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
CLAZF net income · 5 questionsClaritas Pharmaceuticals, Inc. is profitable. The company reported net income of $4.2M for FY2020, a net profit margin of —. Net income was up 119.8% year-over-year. Based on available data, Claritas Pharmaceuticals, Inc. has been profitable since at least 2018.
▸ Source: FMP /income-statement · GAAP · Claritas Pharmaceuticals, Inc. · Claritas Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026